FOXO3A suppresses breast cancer stem cell properties and tumorigenicity via inhibition of FOXM1/SOX2 signaling (Liu et al., 2020; Yan et al., 2017), suggesting that FRMD8 may have an effect on breast cancer stem cells. Here, SOX2 is linked to breast cancer.